VivoSeq
Gastroenterology

Inflammatory Bowel Disease (IBD)

1

Pipeline Programs↗

4

Active Trials↗

1

Companies Involved↗

Inflammatory Bowel Disease (IBD) is an early-stage landscape with 1 program across 1 company. The most active players are Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

1 program

Phase 2

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 21

DISC-0974

Disc Medicine, Inc

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

5

clinical trials

Recruiting2 · 40%
Not yet recruiting2 · 40%
Completed1 · 20%

Clinical Trials

Trial Activity

Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's Disease
Completed·SShanghai 10th People's Hospital·N/A·NCT07697547·84 enrolled
RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation
Recruiting·DDisc Medicine, Inc·Phase 2·NCT07368972·21 enrolled
SHIFT-IBD: Switching to High-efficacy Anti-IL-23 Guselkumab in Ustekinumab-exposed Persons With Active IBD
Recruiting·TTIDHI Innovation Inc.·N/A·NCT07245394·200 enrolled
Acupoint Sensitization in Inflammatory Bowel Disease: A Non-interventional Study
Not yet recruiting·BBrigham and Women's Hospital·N/A·NCT07681895·100 enrolled
Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study
Not yet recruiting·MMaastricht University Medical Center·N/A·NCT07647640·600 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)